Effects of Probucol on Vascular Remodeling After Coronary Angioplasty
نویسندگان
چکیده
Background—We have shown that probucol reduces restenosis after balloon angioplasty. Whether probucol acted via prevention of neointimal formation or improvement in vascular remodeling could not be addressed by angiography and required the use of intravascular ultrasound (IVUS). Methods and Results—Beginning 30 days before angioplasty, 317 patients were randomly assigned to receive probucol, multivitamins, combined treatment, or placebo. Patients were then treated for 6 months after angioplasty. IVUS examination was performed immediately after angioplasty and at follow-up in 94 patients (111 segments). The cross section selected for serial analysis was the one at the angioplasty site with the smallest lumen area at follow-up. In the placebo group, lumen area decreased by 21.2161.88 mm at follow-up, and wall area and external elastic membrane (EEM) area increased by 1.5062.50 and 0.2962.93 mm, respectively. Change in lumen area, however, correlated more strongly with the change in EEM area (r50.53, P50.002) than with the change in wall area (r520.13, P50.49). Lumen loss was 21.2161.88 mm for placebo, 20.8361.22 mm for vitamins, 20.2561.17 mm for combined treatment, and 20.1561.70 mm for probucol alone (P50.002 for probucol, P50.84 for vitamins). Change in wall area was similar for all groups. EEM area increased by 0.2962.93 mm for placebo, 0.0962.33 mm for vitamins only, 1.1761.61 mm for combined treatment, and 1.7461.80 mm for probucol only (P50.005 for probucol). Conclusions—Lumen loss after balloon angioplasty is due to inadequate vessel remodeling in response to neointimal formation. Probucol exerts its antirestenotic effects by improving vascular remodeling after angioplasty. (Circulation. 1999;99:30-35.)
منابع مشابه
Effects of probucol on vascular remodeling after coronary angioplasty. Multivitamins and Protocol Study Group.
BACKGROUND We have shown that probucol reduces restenosis after balloon angioplasty. Whether probucol acted via prevention of neointimal formation or improvement in vascular remodeling could not be addressed by angiography and required the use of intravascular ultrasound (IVUS). METHODS AND RESULTS Beginning 30 days before angioplasty, 317 patients were randomly assigned to receive probucol, ...
متن کاملAntioxidants and prevention of restenosis after directional coronary atherectomy.
Directional Coronary Atherectomy To the Editor: The negative results obtained with carvedilol in the European Carvedilol Atherectomy Restenosis (EUROCARE) trial led Serruys et al1 to question the value of antioxidants for the prevention of restenosis after coronary angioplasty. An important flaw in study design, however, invalidates the conclusions reached by the authors. The antioxidant probuc...
متن کاملPrevention of restenosis after angioplasty in small coronary arteries with probucol.
BACKGROUND Restenosis remains the major limitation of coronary angioplasty. Coronary stents have reduced the incidence of restenosis in selected patients with relatively large vessels. No strategies to date have demonstrated a beneficial effect in vessels < 3.0 mm in diameter. We have shown in the MultiVitamins and Probucol (MVP) Trial that probucol, a potent antioxidant, reduces restenosis aft...
متن کاملEffects of Probucol on Restenosis after Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
BACKGROUND Restenosis after percutaneous coronary intervention (PCI) is a remained clinical problem which limits long-term success of PCI. Although there was recognition that probucol in treating restenosis after percutaneous transluminal coronary angioplasty, the efficacy of probucol on restenosis after stent-implantation is controversial. So this meta-analysis was conducted to investigate the...
متن کاملAntioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging
Oxidative stress is implicated in atherogenesis, yet most clinical trials with antioxidants, particularly vitamin E, have failed to protect against atherosclerotic diseases. A striking exception is probucol, which retards atherosclerosis in carotid arteries and restenosis of coronary arteries after angioplasty. Because probucol has in vitro cellular-protective effects independent of inhibiting ...
متن کامل